A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/404 (2006.01) A61K 31/16 (2006.01) A61K 31/166 (2006.01) A61K 31/40 (2006.01) A61K 31/4045 (2006.01) A61K 31/41 (2006.01) A61K 31/4196 (2006.01) A61K 31/42 (2006.01) A61K 31/445 (2006.01) A61K 31/454 (2006.01) A61K 31/495 (2006.01) A61K 45/00 (2006.01) A61P 25/06 (2006.01) C07D 209/14 (2006.01) C07D 401/00 (2006.01) C07D 403/06 (2006.01)
Patent
CA 2348543
The present invention relates to a method of treating migraine in a mammal, including a human, by administering to the mammal a 5HT1 receptor agonist, and particularly eletriptan, in combination with metoclopramide. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a 5HT1 receptor agonist and metoclopramide.
Procédé de traitement de la migraine chez un mammifère, dont un être humain, qui consiste à administrer à ce mammifère un agoniste de récepteur 5HT¿1?, en particulier de l'élétriptan, en combinaison avec du métoclopramide. La présente invention concerne également des compositions pharmaceutiques contenant un excipient acceptable sur le plan pharmaceutique, un agoniste de récepteur 5HT¿1? et du métoclopramide.
Pfizer Products Inc.
Smart & Biggar
LandOfFree
5ht1 receptor agonists and metoclopramide for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5ht1 receptor agonists and metoclopramide for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5ht1 receptor agonists and metoclopramide for the treatment... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1724519